You are here

  • Home
  • Archive
  • Volume 69, Issue Suppl 2
  • S93 A Prospective Study Investigating Exacerbations, Healthcare Utilisation And Health Economic Indicators In Omalizumab Treated Severe Allergic Asthma Patients – Results From An Interim Analysis Of The Apex Ii Study

Article info

Article menu

Download PDFPDF

New asthma treatments
S93 A Prospective Study Investigating Exacerbations, Healthcare Utilisation And Health Economic Indicators In Omalizumab Treated Severe Allergic Asthma Patients – Results From An Interim Analysis Of The Apex Ii Study
Free

Authors

Citation

Masoli M, Menzies-Gow A, Dobson L, et al
S93 A Prospective Study Investigating Exacerbations, Healthcare Utilisation And Health Economic Indicators In Omalizumab Treated Severe Allergic Asthma Patients – Results From An Interim Analysis Of The Apex Ii Study
Thorax 2014;69:A50-A51.

Publication history

  • First published November 10, 2014.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions